Skip to main content

Advertisement

SpringerLink
Log in

Vestibular and auditory deficits in Fabry disease and their response to enzyme replacement therapy

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Progressive hearing (pHL) and vestibular (pVL) loss are frequent deficits in Fabry disease (FD). Recently, enzyme replacement therapy (ERT) with human α-galactosidase A has become available. Here, we investigate the association between pHL and pVL in FD and their ERT responses. Pure tone audiometry (PTA) and head impulse testing (HIT) were administered at baseline in 47 patients (25 male, 18-0 y; 22 female, 17-4 y), of whom 24 also received caloric irrigation (CI). Of the 47 patients, 38 (24 male) were tested both before and during ERT (follow- up ≤60 months). ERT consisted of agalsidase alfa infusions. At baseline, pHL was present in 88% of males and 86% of females. Over all tested frequencies (range: 0.5- kHz), pHL was significantly (two-way ANOVA: p < 0.05) greater at higher age and in males,with largest deficits at high frequencies. When assessed with HIT, 80% of males and 77% of females had pVL. pVL was significantly greater at higher age and in males. Tested with CI, 21% of males and 0% of females had pVL. No associations among individual semicircular canal (SCC) deficits, as tested by HIT, and hearing was observed in individual ears. After ≥18 months of ERT, pVL was significantly smaller than at baseline (ANOVA for HIT: p < 0.01). In contrast, pHL remained unchanged by ERT over 60 months (p > 0.05). We conclude that pHL and pVL prevalences are similar in FD. To detect pVL, HIT is more sensitive than CI. We speculate that pHL and pVL emerge from lesions within the vestibulocochlear labyrinth, because no specific patterns of vestibulo-cochlear deficits were observed, as expected if lesions were more proximal along the inferior or superior branch of the vestibulo-cochlear nerve or labyrinthine artery. Finally, ERT stabilizes auditory and even improves vestibular function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Allum JH, Ledin T (1999) Recovery of vestibulo-ocular reflex-function in subjects with an acute unilateral peripheral vestibular deficit. J Vestib Res 9:135-44

    CAS  PubMed  Google Scholar 

  2. Aw ST, Fetter M, Cremer PD, Karlberg M, Halmagyi GM (2001) Individual semicircular canal function in superior and inferior vestibular neuritis. Neurology 57:768-74

    CAS  PubMed  Google Scholar 

  3. Aw ST, Halmagyi GM, Haslwanter T, Curthoys IS, Yavor RA, Todd MJ (1996) Three-dimensional vector analysis of the human vestibuloocular reflex in response to high-acceleration head rotations. II responses in subjects with unilateral vestibular loss and selective semicircular canal occlusion. J Neurophysiol 76:4021-030

    CAS  PubMed  Google Scholar 

  4. Aw ST, Haslwanter T, Halmagyi GM, Curthoys IS, Yavor RA, Todd MJ (1996) Three-dimensional vector analysis of the human vestibuloocular reflex in response to high-acceleration head rotations. I. Responses in normal subjects. J Neurophysiol 76:4009-020

    CAS  PubMed  Google Scholar 

  5. Beck M, Ricci R, Widmer U, Dehout F, de Lorenzo AG, Kampmann C, Linhart A, Sunder-Plassmann G, Houge G, Ramaswami U, Gal A, Mehta A (2004) Fabry disease: overall effects of agalsidase alfa treatment. Eur J Clin Invest 34:838-44

    Article  CAS  PubMed  Google Scholar 

  6. Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L (1967) Enzymatic defect in Fabry’s disease. Ceramidetrihexosidase deficiency. N Engl J Med 276:1163-167

    Article  CAS  PubMed  Google Scholar 

  7. Brady RO, Schiffmann R (2000) Clinical features of and recent advances in therapy for Fabry disease. JAMA 284:2771-775

    Article  CAS  PubMed  Google Scholar 

  8. Brantberg K, Magnusson M (1990) The dynamics of the vestibulo-ocular reflex in patients with vestibular neuritis. Am J Otolaryngol 11:345-51

    Article  CAS  PubMed  Google Scholar 

  9. Conti G, Sergi B (2003) Auditory and vestibular findings in Fabry disease: a study of hemizygous males and heterozygous females. Acta Paediatr Suppl 92:33-7

    Article  CAS  PubMed  Google Scholar 

  10. Desnick, R, Ioannou, Y, Eng, C (2001) α-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. New York:McGraw-Hill, pp 3733-774

    Google Scholar 

  11. Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, Caplan L, Linthorst GE, Desnick RJ (2001) Safety and efficacy of recombinant human alpha-galactosidase A-replacement therapy in Fabry’s disease. N Engl J Med 345:9-6

    Article  CAS  PubMed  Google Scholar 

  12. Fetter M, Dichgans J (1996) Vestibular neuritis spares the inferior division of the vestibular nerve. Brain 119:755-63

    Article  PubMed  Google Scholar 

  13. Fitzgerald G, Hallpike C (1942) Studies in human vestibular function. I. Observations of the directional preponderance of caloric nystagmus resulting from cerebral lesions. Brain 65:115-37

    Article  Google Scholar 

  14. Germain DP, Avan P, Chassaing A, Bonfils P (2002) Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients. BMC Med Genet 3:10

    Article  PubMed  Google Scholar 

  15. Hajioff D, Goodwin S, Quiney R, Zuckerman J, MacDermot KD, Mehta A (2003) Hearing improvement in patients with Fabry disease treated with agalsidase alfa. Acta Paediatr Suppl 92:28-0

    Article  CAS  PubMed  Google Scholar 

  16. Hajioff D, Hegemann S, Conti G, Beck M, Sunder-Plassmann G, Widmer U, Mehta A, Keilmann A (2006) Agalsidase alpha and hearing in Fabry disease: data from the Fabry Outcome Survey. Eur J Clin Invest 36:663-67

    Article  CAS  PubMed  Google Scholar 

  17. Halmagyi GM, Curthoys IS, Cremer PD, Henderson CJ, Todd MJ, Staples MJ, D'Cruz DM (1990) The human horizontal vestibulo-ocular reflex in response to high-acceleration stimulation before and after unilateral vestibular neurectomy. Exp Brain Res 81:479-90

    Article  CAS  PubMed  Google Scholar 

  18. Hegemann S, Hajioff D, Conti G, Beck M, Sunder-Plassmann G, Widmer U, Mehta A, Keilmann A (2006) Hearing loss in Fabry disease: data from the Fabry Outcome Survey. Eur J Clin Invest 36:654-62

    Article  CAS  PubMed  Google Scholar 

  19. Hilz MJ, Brys M, Marthol H, Stemper B, Dutsch M (2004) Enzyme replacement therapy improves function of C-, Adelta-, and Abeta-nerve fibers in Fabry neuropathy. Neurology 62:1066-072

    CAS  PubMed  Google Scholar 

  20. Imate Y, Sekitani T (1993) Vestibular compensation in vestibular neuronitis. Long-term follow-up evaluation. Acta Otolaryngol 113:463-65

    Article  CAS  PubMed  Google Scholar 

  21. Jongkees LBW (1966) The evaluation of the vestibular caloric test. In:Wolfson RJ (ed) The vestibular system and its diseases. University of Pennsylvania Press Philadelphia, pp 323

  22. Kint JA (1970) Fabry’s disease: alphagalactosidase deficiency. Science 167:1268-269

    Article  CAS  PubMed  Google Scholar 

  23. Lasker DM, Hullar TE, Minor LB (2000) Horizontal vestibuloocular reflex evoked by high-acceleration rotations in the squirrel monkey. III. Responses after labyrinthectomy. J Neurophysiol 83:2482-496

    CAS  PubMed  Google Scholar 

  24. MacDermot KD, Holmes A, Miners AH (2001) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 38:769-75

    Article  CAS  PubMed  Google Scholar 

  25. MacDermot KD, Holmes A, Miners AH (2001) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet 38:750-60

    Article  CAS  PubMed  Google Scholar 

  26. Mehta A, Ricci R, Widmer U, Dehout F, Garcia de LA, Kampmann C, Linhart A, Sunder-Plassmann G, Ries M, Beck M (2004) Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 34:236-42

    Article  CAS  PubMed  Google Scholar 

  27. Meikle PJ, Hopwood JJ, Clague AE, Carey WF (1999) Prevalence of lysosomal storage disorders. JAMA 281:249-54

    Article  CAS  PubMed  Google Scholar 

  28. Minor LB, Lasker DM, Backous DD, Hullar TE (1999) Horizontal vestibuloocular reflex evoked by high-acceleration rotations in the squirrel monkey. I. Normal responses. J Neurophysiol 82:1254-270

    CAS  PubMed  Google Scholar 

  29. Morgan SH, Rudge P, Smith SJ, Bronstein AM, Kendall BE, Holly E, Young EP, Crawfurd MD, Bannister R (1990) The neurological complications of Anderson-Fabry disease (alpha-galactosidase A deficiency)-investigation of symptomatic and presymptomatic patients. Q J Med 75:491-07

    CAS  PubMed  Google Scholar 

  30. Paige GD (1989) Nonlinearity and asymmetry in the human vestibuloocular reflex. Acta Otolaryngol 108:1-

    Article  CAS  PubMed  Google Scholar 

  31. Palla A, Straumann D (2004) Recovery of the high-acceleration vestibuloocular reflex after vestibular neuritis. J Assoc Res Otolaryngol 5:427-35

    Article  CAS  PubMed  Google Scholar 

  32. Palla A, Widmer U, Straumann D (2003) Head-impulse testing in Fabry disease-vestibular function in male and female patients. Acta Paediatr Suppl 92:38-2

    Article  CAS  PubMed  Google Scholar 

  33. Rambold H, Boenki J, Stritzke G, Wisst F, Neppert B, Helmchen C (2005) Differential vestibular dysfunction in sudden unilateral hearing loss. Neurology 64:148-51

    CAS  PubMed  Google Scholar 

  34. Ries M, Kim HJ, Zalewski CK, Mastroianni MA, Moore DF, Brady RO, Dambrosia JM, Schiffmann R, Brewer CC (2006) Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease. Brain 130:143-50

    Article  PubMed  Google Scholar 

  35. Schachern PA, Shea DA, Paparella MM, Yoon TH (1989) Otologic histopathology of Fabry’s disease. Ann Otol Rhinol Laryngol 98:359-63

    CAS  PubMed  Google Scholar 

  36. Schiffmann R, Kopp JB, Austin HA III, Sabnis S, Moore DF, Weibel T, Balow JE, Brady RO (2001) Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 285:2743-749

    Article  CAS  PubMed  Google Scholar 

  37. Schmid-Priscoveanu A, Bohmer A, Obzina H, Straumann D (2001) Caloric and search-coil head-impulse testing in patients after vestibular neuritis. J Assoc Res Otolaryngol 2:72-8

    CAS  PubMed  Google Scholar 

  38. Schmid-Priscoveanu A, Straumann D, Bohmer A, Obzina H (1999) Vestibuloocular responses during static head roll and three-dimensional head impulses after vestibular neuritis. Acta Otolaryngol 119:750-57

    Article  CAS  PubMed  Google Scholar 

  39. Spada M, Pagliardini S, Yasuda M, Tukel T, Thiagarajan G, Sakuraba H, Ponzone A, Desnick RJ (2006) High incidence of later-onset Fabry disease revealed by newborn screening. Am J Hum Genet 79:31-0

    Article  CAS  PubMed  Google Scholar 

  40. Spinelli L, Pisani A, Sabbatini M, Petretta M, Andreucci MV, Procaccini D, Lo SN, Federico S, Cianciaruso B (2004) Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry’s disease. Clin Genet 66:158-65

    Article  CAS  PubMed  Google Scholar 

  41. Straumann D, Zee DS, Solomon D, Lasker AG, Roberts DC (1995) Transient torsion during and after saccades. Vision Res 35:3321-334

    Article  CAS  PubMed  Google Scholar 

  42. Whybra C, Kampmann C, Willers I, Davies J, Winchester B, Kriegsmann J, Bruhl K, Gal A, Bunge S, Beck M (2001) Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes. J Inherit Metab Dis 24:715-24

    Article  CAS  PubMed  Google Scholar 

  43. Wilcox WR, Banikazemi M, Guffon N, Waldek S, Lee P, Linthorst GE, Desnick RJ, Germain DP (2004) Long-term safety and efficacy of enzyme replacement therapy for Fabry disease. Am J Hum Genet 75:65-4

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurology Department, Zurich University Hospital, Frauenklinikstrasse 26, 8091, Zurich, Switzerland

    A. Palla MD & D. Straumann MD

  2. Dept. of Otolaryngology,Head & Neck Surgery, Zurich University Hospital, Switzerland

    S. Hegemann MD

  3. Dept. of Medicine, Zurich University Hospital, Switzerland

    U. Widmer MD

Authors
  1. A. Palla MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Hegemann MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. U. Widmer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Straumann MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Palla MD.

Additional information

Grant/financial support: Swiss National Science Foundation (#3200B0-05434); Betty and David Koetser, Foundation for Brain Research, Zurich, Switzerland.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Palla, A., Hegemann, S., Widmer, U. et al. Vestibular and auditory deficits in Fabry disease and their response to enzyme replacement therapy. J Neurol 254, 1433–1442 (2007). https://doi.org/10.1007/s00415-007-0575-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-007-0575-y

Key words

Search

Navigation